/PRNewswire/ Unity HA announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the Pulsante® SPG.
Unity HA Awarded Breakthrough Device Designation for Implantable Neurostimulation Technology to Treat Cluster Headache Pain prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.